首页 > 市场调查报告书 > 製药

自体免疫疾病

市场调查报告书

商品编码

1819898

2025-2033 年抗风湿药物市场报告（按类型、药品类别、给药途径、配销通路和地区）

Anti-Rheumatics Market Report by Type, Drug Class, Route of Drug Administration, Distribution Channel, and Region 2025-2033

出版日期: 2025年09月01日 | 出版商:

IMARC | 英文 143 Pages | 商品交期: 2-3个工作天内

价格

简介目录图表

2024年，全球抗风湿药市场规模达661亿美元。展望未来， IMARC Group预计到2033年，市场规模将达到818亿美元，2025-2033年期间的复合年增长率（CAGR）为2.28%。全球老化人口的不断增加、医院、诊所和其他医疗机构的扩张，以及大型製药公司和医疗中心之间合作关係的不断扩大，是推动市场成长的主要因素。

抗风湿药是用于治疗关节、肌肉和结缔组织疾病的药物。它们有助于减轻发炎、疼痛和僵硬，并减缓疾病进展。抗风湿药有多种类型，包括非类固醇抗发炎药 (NSAID)、改善病情的抗风湿药 (DMARD) 和生物製剂。它们可以透过口服、皮下注射和静脉注射的方式给药。它们针对的是导致组织损伤和发炎的潜在机制。抗风湿药物通常在经过全面诊断后开立，并联合使用以获得最佳效果。

由于不健康的饮食习惯和缺乏运动，风湿病的盛行率不断上升，这是催生有效治疗需求的关键因素之一。此外，奈米颗粒载体或缓释胶囊等药物传递系统的不断发展，正在提升抗风湿药物的疗效和便利性。此外，远距医疗服务的成长使得疾病管理更加便捷，处方续药更加便捷，从而促进了抗风湿药物的持续使用。此外，医疗保健系统向新兴市场的扩展，使医疗资源匮乏的人更容易获得抗风湿药物。基因组学和个人化医疗的进步，使得更有针对性的治疗成为可能，并提高了抗风湿药物的有效性。

抗风湿药市场趋势/驱动因素：

人口老化加剧

人口老化加剧，更容易患骨关节炎和类风湿性关节炎等关节疾病，这是推动市场成长的关键因素之一。此外，老年人口往往患有多种疾病，这些疾病可能会加重风湿性疾病，因此需要更复杂、更长期的治疗策略。此外，各国政府部门和医疗体係也意识到了这一日益增长的需求，并正在增加医疗预算，以应对老龄化社会带来的挑战。製药公司也正致力于研发更有效、更安全的抗风湿药物。因此，预计未来几年此类药物的市场将大幅成长。

策略合作与合併

製药公司和医疗机构之间策略合作、併购 (M&A) 的不断增加是推动市场成长的另一个重要因素。这些合作通常包含知识共享协议，使其更容易规避监管障碍，并缩短新药的上市时间。此外，大型製药公司和生技新创公司之间不断扩大的合作关係，也加快了新型抗风湿药物的开发和商业化进程。此外，它还促进了研发 (R&D) 活动，从而推出更先进的药物。此外，这些合作促进了抗风湿药物的便利供应，使其能够进入先前尚未开发的市场，从而促进全球市场的成长。

提高对早期诊断和预防的认识

人们对早期诊断和预防类风湿性疾病益处的认识不断提高，这促进了市场的成长。早期诊断可以更有效地管理疾病，通常需要使用抗风湿药物。此外，人们越来越依赖社群媒体管道来推广医学教育，这也对市场产生了正面的影响。此外，一些国家的政府部门正在组织公共卫生运动，这为市场带来了良好的前景。此外，先进诊断工具的发展使医疗保健专业人员更容易在早期识别风湿性疾病。这种积极主动的方法增加了对抗风湿药物的市场需求，因为及时介入需要药物来控制症状和改善病情。

The global anti-rheumatics market size reached USD 66.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 81.8 Billion by 2033, exhibiting a growth rate (CAGR) of 2.28% during 2025-2033. The increasing aging population across the globe, expansion of hospitals, clinics, and other healthcare facilities, and the expanding partnerships between large pharmaceutical companies and healthcare centers are some of the major factors propelling the market growth.

Anti-rheumatics are medications used to treat diseases affecting the joints, muscles, and connective tissues. They help reduce inflammation, pain, and stiffness, and slow the progression of the disease. They are available in various classes, including non-steroidal anti-inflammatory drugs (NSAIDs), disease-modifying anti-rheumatic drugs (DMARDs), and biologics. They can be administered orally, subcutaneously and intravenously into the body. They target the underlying mechanisms that lead to tissue damage and inflammation. They are generally prescribed after a thorough diagnosis and are used in combination for optimum results.

The rising prevalence of rheumatic diseases due to unhealthy dietary patterns and lack of physical activity represent one of the key factors catalyzing the demand for effective treatments. Additionally, continuous development in drug delivery systems, like nanoparticle-based carriers or time-release capsules, is enhancing the efficacy and convenience of anti-rheumatic medications. Apart from this, the growth of telehealth services is enabling better disease management and easier prescription refills, promoting consistent use of anti-rheumatic drugs. Furthermore, the expansion of healthcare systems into emerging markets is making anti-rheumatic medications more accessible to underserved populations. Moreover, advancements in genomics and personalized medicine are allowing for more targeted treatments and improving the effectiveness of anti-rheumatic medications.

Anti-Rheumatics Market Trends/Drivers:

Rising aging population

The increasing aging population, which is more susceptible to joint disorders, such as osteoarthritis and rheumatoid arthritis, represents one of the key factors augmenting the market growth. Moreover, older populations often have multiple health conditions that can exacerbate rheumatic diseases, thus requiring more complex and long-term treatment strategies. Additionally, governing authorities and healthcare systems of various countries are recognizing this growing need and are increasing healthcare budgets to address the challenges of an aging society. Pharmaceutical companies are also focusing their research and development efforts on creating more effective and safer anti-rheumatic medications. As a result, the market for these drugs is expected to grow substantially in the coming years.

Strategic collaborations and mergers

The increasing number of strategic collaborations, mergers, and acquisitions (M&A) among pharmaceutical companies and healthcare facilities is another major factor contributing to the market growth. They often include knowledge-sharing agreements, making it easier to navigate regulatory hurdles and reducing the time-to-market for new medications. Additionally, the expanding partnerships between large pharmaceutical companies and biotech startups result in the faster development and commercialization of new anti-rheumatic drugs. Apart from this, it facilitates research and development (R&D) activities to introduce more advanced drugs. Furthermore, these collaborations promote an easy supply of anti-rheumatic drugs to reach previously untapped markets, contributing to global market growth.

Rising awareness about early diagnosis and prevention

The rising awareness among individuals about the benefits of early diagnosis and prevention of rheumatoid diseases is strengthening the growth of the market. Early diagnosis allows for more effective management of the disease, often requiring the use of anti-rheumatic drugs. Additionally, the increasing reliance of people on social media channels promoting medical education is positively influencing the market. Furthermore, the governing authorities of several countries are organizing public health campaigns, which is offering a favorable market outlook. Moreover, the development of advanced diagnostic tools has made it easier for healthcare professionals to identify rheumatic diseases at an early stage. This proactive approach enhances the market demand for anti-rheumatics, as timely intervention necessitates medication for symptom management and disease modification.

Anti-Rheumatics Industry Segmentation:

Breakup by Type:

Prescription-based Drugs
Over-the-Counter Drugs

Prescription-based drugs account for the majority of the market share

Breakup by Drug Class:

Disease Modifying Anti-Rheumatics Drugs (DMARD's)
Nonsteroidal Anti-Inflammatory Drugs (NSAID's)
Corticosteroids
Uric Acid Drugs
Others

Disease modifying anti-rheumatics drugs (DMARD's) hold the largest share in the industry

Breakup by Route of Drug Administration:

Oral
Parenteral
Others

Parenteral represents the leading market segment

Breakup by Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
E-Commerce

Hospital pharmacies exhibit a clear dominance in the market

Breakup by Region:

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

North America leads the market, accounting for the largest anti-rheumatics market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share since the region is a hub for pharmaceutical research and development (R&D). Additionally, North America, particularly the United States, has a well-established healthcare system equipped with state-of-the-art medical facilities. This superior infrastructure allows for the early diagnosis and comprehensive treatment of rheumatic diseases, which naturally leads to a higher demand for anti-rheumatic medications. Along with this, the widespread availability of specialized rheumatology clinics and medical professionals further drives the need for these drugs. Apart from this, the regulatory environment in North America, led by agencies like the U.S. Food and Drug Administration (FDA), is highly supportive of medical advancements. Furthermore, the increasing aging population in the region is driving the demand for anti-rheumatics.

Competitive Landscape:

Companies are investing heavily in the development of new anti-rheumatic drugs, targeting existing and emerging therapeutic mechanisms. Additionally, many companies are entering into partnerships, mergers, and acquisitions. These strategic collaborations often involve sharing technology, resources, and market channels. Apart from this, they are also focusing on expanding market access through various channels. This often involves launching products in new geographical markets, increasing production capacities, or diversifying supply chains to ensure more reliable distribution. Furthermore, various companies are using analytics to identify market trends, patient preferences, and treatment outcomes. Moreover, they are investing in educational programs for healthcare providers, patients, and the public.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

AbbVie Inc.
Amgen Inc.
AstraZeneca plc
Biogen Inc.
Bristol-Myers Squibb Company
Celltrion Inc.
Eli Lilly and Company
F. Hoffmann-La Roche AG
Johnson & Johnsons
Pfizer Inc.
Sanofi SA

Key Questions Answered in This Report

1.What was the size of the global anti-rheumatics market in 2024?
2.What is the expected growth rate of the global anti-rheumatics market during 2025-2033?
3.What are the key factors driving the global anti-rheumatics market?
4.What has been the impact of COVID-19 on the global anti-rheumatics market?
5.What is the breakup of the global anti-rheumatics market based on the type?
6.What is the breakup of the global anti-rheumatics market based on the drug class?
7.What is the breakup of the global anti-rheumatics market based on the route of drug administration?
8.What is the breakup of the global anti-rheumatics market based on the distribution channel?
9.What are the key regions in the global anti-rheumatics market?
10.Who are the key players/companies in the global anti-rheumatics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Anti-Rheumatics Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Type

6.1 Prescription-based Drugs
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Over-the-Counter Drugs
- 6.2.1 Market Trends
- 6.2.2 Market Forecast

7 Market Breakup by Drug Class

7.1 Disease Modifying Anti-Rheumatics Drugs (DMARD's)
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Nonsteroidal Anti-Inflammatory Drugs (NSAID's)
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Corticosteroids
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Uric Acid Drugs
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Others
- 7.5.1 Market Trends
- 7.5.2 Market Forecast

8 Market Breakup by Route of Drug Administration

8.1 Oral
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Parenteral
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Others
- 8.3.1 Market Trends
- 8.3.2 Market Forecast

9 Market Breakup by Distribution Channel

9.1 Hospital Pharmacies
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Retail Pharmacies
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 E-Commerce
- 9.3.1 Market Trends
- 9.3.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia-Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 AbbVie Inc.
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
  - 15.3.1.3 Financials
  - 15.3.1.4 SWOT Analysis
- 15.3.2 Amgen Inc.
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
  - 15.3.2.3 Financials
  - 15.3.2.4 SWOT Analysis
- 15.3.3 AstraZeneca plc
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
  - 15.3.3.3 Financials
  - 15.3.3.4 SWOT Analysis
- 15.3.4 Biogen Inc.
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
  - 15.3.4.3 Financials
  - 15.3.4.4 SWOT Analysis
- 15.3.5 Bristol-Myers Squibb Company
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
  - 15.3.5.3 Financials
  - 15.3.5.4 SWOT Analysis
- 15.3.6 Celltrion Inc.
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
  - 15.3.6.3 Financials
  - 15.3.6.4 SWOT Analysis
- 15.3.7 Eli Lilly and Company
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
  - 15.3.7.3 Financials
  - 15.3.7.4 SWOT Analysis
- 15.3.8 F. Hoffmann-La Roche AG
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
  - 15.3.8.3 Financials
- 15.3.9 Johnson & Johnsons
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio
  - 15.3.9.3 Financials
  - 15.3.9.4 SWOT Analysis
- 15.3.10 Pfizer Inc.
  - 15.3.10.1 Company Overview
  - 15.3.10.2 Product Portfolio
  - 15.3.10.3 Financials
  - 15.3.10.4 SWOT Analysis
- 15.3.11 Sanofi SA
  - 15.3.11.1 Company Overview
  - 15.3.11.2 Product Portfolio
  - 15.3.11.3 Financials
  - 15.3.11.4 SWOT Analysis

简介目录图表

List of Figures

Figure 1: Global: Anti-Rheumatics Market: Major Drivers and Challenges
Figure 2: Global: Anti-Rheumatics Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Anti-Rheumatics Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Anti-Rheumatics Market: Breakup by Type (in %), 2024
Figure 5: Global: Anti-Rheumatics Market: Breakup by Drug Class (in %), 2024
Figure 6: Global: Anti-Rheumatics Market: Breakup by Route of Drug Administration (in %), 2024
Figure 7: Global: Anti-Rheumatics Market: Breakup by Distribution Channel (in %), 2024
Figure 8: Global: Anti-Rheumatics Market: Breakup by Region (in %), 2024
Figure 9: Global: Anti-Rheumatics (Prescription-based Drugs) Market: Sales Value (in Million USD), 2019 & 2024
Figure 10: Global: Anti-Rheumatics (Prescription-based Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 11: Global: Anti-Rheumatics (Over-the-Counter Drugs) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12: Global: Anti-Rheumatics (Over-the-Counter Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 13: Global: Anti-Rheumatics (Disease Modifying Anti-Rheumatics Drugs (DMARD's)) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: Global: Anti-Rheumatics (Disease Modifying Anti-Rheumatics Drugs (DMARD's)) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: Global: Anti-Rheumatics (Nonsteroidal Anti-Inflammatory Drugs (NSAID's)) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: Global: Anti-Rheumatics (Nonsteroidal Anti-Inflammatory Drugs (NSAID's)) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: Global: Anti-Rheumatics (Corticosteroids) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: Global: Anti-Rheumatics (Corticosteroids) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: Global: Anti-Rheumatics (Uric Acid Drugs) Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: Global: Anti-Rheumatics (Uric Acid Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: Global: Anti-Rheumatics (Other Drug Classes) Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: Global: Anti-Rheumatics (Other Drug Classes) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: Global: Anti-Rheumatics (Oral) Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: Global: Anti-Rheumatics (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: Global: Anti-Rheumatics (Parenteral) Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: Global: Anti-Rheumatics (Parenteral) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: Global: Anti-Rheumatics (Other Routes of Drug Administration) Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: Global: Anti-Rheumatics (Other Routes of Drug Administration) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: Global: Anti-Rheumatics (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: Global: Anti-Rheumatics (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: Global: Anti-Rheumatics (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 32: Global: Anti-Rheumatics (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 33: Global: Anti-Rheumatics (E-Commerce) Market: Sales Value (in Million USD), 2019 & 2024
Figure 34: Global: Anti-Rheumatics (E-Commerce) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 35: North America: Anti-Rheumatics Market: Sales Value (in Million USD), 2019 & 2024
Figure 36: North America: Anti-Rheumatics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 37: United States: Anti-Rheumatics Market: Sales Value (in Million USD), 2019 & 2024
Figure 38: United States: Anti-Rheumatics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 39: Canada: Anti-Rheumatics Market: Sales Value (in Million USD), 2019 & 2024
Figure 40: Canada: Anti-Rheumatics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 41: Asia-Pacific: Anti-Rheumatics Market: Sales Value (in Million USD), 2019 & 2024
Figure 42: Asia-Pacific: Anti-Rheumatics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 43: China: Anti-Rheumatics Market: Sales Value (in Million USD), 2019 & 2024
Figure 44: China: Anti-Rheumatics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 45: Japan: Anti-Rheumatics Market: Sales Value (in Million USD), 2019 & 2024
Figure 46: Japan: Anti-Rheumatics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 47: India: Anti-Rheumatics Market: Sales Value (in Million USD), 2019 & 2024
Figure 48: India: Anti-Rheumatics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 49: South Korea: Anti-Rheumatics Market: Sales Value (in Million USD), 2019 & 2024
Figure 50: South Korea: Anti-Rheumatics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 51: Australia: Anti-Rheumatics Market: Sales Value (in Million USD), 2019 & 2024
Figure 52: Australia: Anti-Rheumatics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 53: Indonesia: Anti-Rheumatics Market: Sales Value (in Million USD), 2019 & 2024
Figure 54: Indonesia: Anti-Rheumatics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 55: Others: Anti-Rheumatics Market: Sales Value (in Million USD), 2019 & 2024
Figure 56: Others: Anti-Rheumatics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 57: Europe: Anti-Rheumatics Market: Sales Value (in Million USD), 2019 & 2024
Figure 58: Europe: Anti-Rheumatics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 59: Germany: Anti-Rheumatics Market: Sales Value (in Million USD), 2019 & 2024
Figure 60: Germany: Anti-Rheumatics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 61: France: Anti-Rheumatics Market: Sales Value (in Million USD), 2019 & 2024
Figure 62: France: Anti-Rheumatics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 63: United Kingdom: Anti-Rheumatics Market: Sales Value (in Million USD), 2019 & 2024
Figure 64: United Kingdom: Anti-Rheumatics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 65: Italy: Anti-Rheumatics Market: Sales Value (in Million USD), 2019 & 2024
Figure 66: Italy: Anti-Rheumatics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 67: Spain: Anti-Rheumatics Market: Sales Value (in Million USD), 2019 & 2024
Figure 68: Spain: Anti-Rheumatics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 69: Russia: Anti-Rheumatics Market: Sales Value (in Million USD), 2019 & 2024
Figure 70: Russia: Anti-Rheumatics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 71: Others: Anti-Rheumatics Market: Sales Value (in Million USD), 2019 & 2024
Figure 72: Others: Anti-Rheumatics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 73: Latin America: Anti-Rheumatics Market: Sales Value (in Million USD), 2019 & 2024
Figure 74: Latin America: Anti-Rheumatics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 75: Brazil: Anti-Rheumatics Market: Sales Value (in Million USD), 2019 & 2024
Figure 76: Brazil: Anti-Rheumatics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 77: Mexico: Anti-Rheumatics Market: Sales Value (in Million USD), 2019 & 2024
Figure 78: Mexico: Anti-Rheumatics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 79: Others: Anti-Rheumatics Market: Sales Value (in Million USD), 2019 & 2024
Figure 80: Others: Anti-Rheumatics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 81: Middle East and Africa: Anti-Rheumatics Market: Sales Value (in Million USD), 2019 & 2024
Figure 82: Middle East and Africa: Anti-Rheumatics Market: Breakup by Country (in %), 2024
Figure 83: Middle East and Africa: Anti-Rheumatics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 84: Global: Anti-Rheumatics Industry: SWOT Analysis
Figure 85: Global: Anti-Rheumatics Industry: Value Chain Analysis
Figure 86: Global: Anti-Rheumatics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Anti-Rheumatics Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Anti-Rheumatics Market Forecast: Breakup by Type (in Million USD), 2025-2033
Table 3: Global: Anti-Rheumatics Market Forecast: Breakup by Drug Class (in Million USD), 2025-2033
Table 4: Global: Anti-Rheumatics Market Forecast: Breakup by Route of Drug Administration (in Million USD), 2025-2033
Table 5: Global: Anti-Rheumatics Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
Table 6: Global: Anti-Rheumatics Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 7: Global: Anti-Rheumatics Market: Competitive Structure
Table 8: Global: Anti-Rheumatics Market: Key Players

02-2729-4219

+886-2-2729-4219

License/价格

2025-2033 年抗风湿药物市场报告（按类型、药品类别、给药途径、配销通路和地区）

Anti-Rheumatics Market Report by Type, Drug Class, Route of Drug Administration, Distribution Channel, and Region 2025-2033

抗风湿药市场趋势/驱动因素：

目录

第一章：前言

第二章：范围与方法

第三章：执行摘要

第四章：简介

第五章：全球抗风湿药市场

第六章：市场细分：依类型

第七章：市场区隔：依药品类别

第八章：市场区隔：依药品管理途径

第九章：市场区隔：按配销通路

第十章：市场细分：按地区

第 11 章：SWOT 分析

第 12 章：价值链分析

第 13 章：波特五力分析

第 14 章：价格分析

第 15 章：竞争格局